Lung Disease and Genomics

AACN Advanced Critical Care
Kenneth Wysocki

Abstract

Research and application of genomic medicine in lung disease during the past century has clarified our understanding and focus on specific phenotypes, helping clinicians tailor treatment for individual patients. Cystic fibrosis and lung cancer have been researched extensively; specific genotypes have been instrumental in precision medicine to treat these lung diseases. Asthma and chronic obstructive pulmonary disease are more complex and heterogeneous in their pathogenesis, genotypic profile, and phenotypic expression, making treatment more difficult with increasing disease severity. This article focuses on the evolving state of the science of precision medicine in lung cancer, chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The body of knowledge in lung disease is growing related to pharmacogenomics, clinical guidelines, genome editing, and approaches to genomic health that will guide clinical treatment options, reduce risk, and promote health.

References

Jul 9, 1998·American Journal of Respiratory and Critical Care Medicine·A A LitonjuaD R Gold
Aug 10, 2000·Neoplasia : an International Journal for Oncology Research·O K PickeralJ Zhang
Nov 15, 2002·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Giuseppe Giaccone
Aug 16, 2005·Clinical Genetics·C Prasad, P A Galbraith
Mar 7, 2007·Clinical Pharmacology and Therapeutics·K M GiacominiUNKNOWN Pharmacogenetics Research Network
Jul 27, 2007·The New England Journal of Medicine·Albert-László Barabási
Feb 6, 2010·The Journal of Pediatrics·Bruce C Marshall, Preston W Campbell
Nov 15, 2011·The European Respiratory Journal·M ThomsenM Dahl
Mar 1, 2012·The Pharmacogenomics Journal·E B MougeyJ J Lima
Jan 1, 2011·Annual Review of Nursing Research·Kenneth Wysocki, Leslie Ritter
Dec 29, 2013·The Journal of Allergy and Clinical Immunology·Victor E Ortega, Deborah A Meyers
Jan 17, 2015·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·J AbbottA L Quittner
Jan 31, 2015·The New England Journal of Medicine·Francis S Collins, Harold Varmus
Oct 20, 2015·Progress in Molecular Biology and Translational Science·Frank C Mooren, Karsten Krüger
Jan 10, 2016·Health Promotion International·Gemma CareyPhilip Baker
Mar 2, 2016·European Respiratory Review : an Official Journal of the European Respiratory Society·Emmanuelle KempfLuis Paz-Ares
Aug 11, 2016·American Journal of Respiratory Cell and Molecular Biology·Lystra P HaydenUNKNOWN COPDGene Investigators *
Feb 22, 2017·Antioxidants·Marko IvancichNeelu Puri
May 31, 2017·Journal of Midwifery & Women's Health·Mary C Brucker, Tekoa L King
Jul 19, 2017·Molecular Genetics & Genomic Medicine·Alison Johnston, Michael Sugrue
Sep 26, 2017·Intractable & Rare Diseases Research·Abhinav AgrawalJanice Wang
Oct 11, 2017·Frontiers in Medicine·Amarpreet KaurDavid A Schwartz
Jan 3, 2018·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Ellen LiuVeronica Franco
Jan 1, 2017·Database : the Journal of Biological Databases and Curation·Yuan LiuDong Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

Nefrología : publicación oficial de la Sociedad Española Nefrologia
E Coto
American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Philip E Empey
© 2022 Meta ULC. All rights reserved